Retraction: Vimentin Is a Novel Anti-Cancer Therapeutic Target; Insights from In Vitro and In Vivo Mice Xenograft Studies.
Main Author: | PLOS ONE Editors |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6428321?pdf=render |
Similar Items
-
Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studies.
by: Guy Lahat, et al.
Published: (2010-04-01) -
Retraction: The Cellular Distribution of Serotonin Transporter Is Impeded on Serotonin-Altered Vimentin Network.
by: PLOS ONE Editors
Published: (2019-01-01) -
Retraction: Potent Anti-Proliferative, Pro-Apoptotic Activity of the Maytenus Royleanus Extract against Prostate Cancer Cells: Evidence in In-Vitro and In-Vivo Models.
by: PLOS ONE Editors
Published: (2024-01-01) -
Retraction: Concomitant Targeting of EGF Receptor, TGF-beta and Src Points to a Novel Therapeutic Approach in Pancreatic Cancer.
by: PLOS ONE Editors
Published: (2020-01-01) -
Retraction: Indole-3-Carbinol Inhibits Nasopharyngeal Carcinoma Growth through Cell Cycle Arrest In Vivo and In Vitro.
by: PLOS ONE Editors
Published: (2022-01-01)